




The Combined Effects of Arsenite and Ethanol on Brain 
Endothelial Cells and Microglial Cells 
By Siying Li 




Submitted to the graduate degree program in Pharmacology and Toxicology and the 
Graduate Faculty of the University of Kansas in partial fulfillment of the requirements  





                                                                                                                  
                                                                            Chair: Dr. Honglian Shi 
                                                                                                                  
                                                                               Dr. Jackob Moskovitz  
                                                                                                                  



















The thesis committee for Siying Li certifies that this is the 
approved version of the following thesis: 
 
The Combined Effects of Arsenite and Ethanol on Brain 




                                                                                                              














Arsenic (As) is a natural compound widely distributed in air, water, and soil. Drinking 
ground water is the major source of As exposure. As exposure causes many health issues, 
including nausea, vomiting, pain, diarrhea, cancer and neurotoxicity [1]. Alcohol drinks 
may also contain As because grapes and rice which are used in making wine and beer, take 
up As from soil, water, and fungicides containing As. Emerged evidence showed that 
ethanol (EtOH) also impairs neurological functions [2]. However, the combined toxic 
effects of As and EtOH on the brain is still unclear. Our long-term goal is to understand the 
effects of As combined with EtOH on the blood brain barrier (BBB).  
The BBB controls molecule exchange between peripheral and cerebral compartments 
[3]. Alterations of the BBB are a critical risk factor of pathology and progression of 
different neurological diseases [4]. Many studies have shown that As as well as EtOH 
induced BBB abnormalities [5, 6]. Since brain endothelial cells play a crucial role in the 
BBB, we used Rat Brain Endothelia (RBE4) cells to investigate the combined toxic effects 
of As and EtOH on the BBB. 
Overproduction of reactive oxygen species (ROS) results in destruction of cellular 
structures, lipid, and proteins [7]. Previously, our lab showed that As increased endothelial 
cell permeability through a ROS-vascular endothelial growth factor pathway in mouse brain 
vascular endothelial cells (bEnd 3 cells) [8]. Others have shown that EtOH also impairs the 
barrier function and junctional organization of human brain microvascular endothelial cell 
monolayer [9]. In neurons, EtOH-induced ROS mainly come from damaged mitochondria 
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[10]. Since mitochondria are major source of ROS generation, we proposed that As-EtOH-
combined treatment impairs the BBB through ROS released by damaged mitochondria. 
Mitochondrial oxidative stress affected microglia-associated neurodegenerative 
diseases through their role as pro-inflammatory molecules and modulators of pro-
inflammatory processes [11]. BBB disruption is mediated by neuroinflammation which is 
associated with increase in pro-inflammatory cytokines [12]. Research showed that 
inflammatory mediators control BBB permeability through regulating the structural 
components [13]. As induced cytotoxicity in brains via regulation of oxidative stress and 
TNF-a associated inflammatory pathways [14]. Alcohol consumption enhanced oxidative 
and inflammatory stress, resulting in cognitive deficit [15]. Since microglial cells are the 
main effectors in the inflammatory process of the central nervous system [16], we used 
microglial cells (BV2) to investigate the combined effects of As and EtOH on microglia. 
Our results showed that As and EtOH increased RBE4 cell monolayer permeability. 
As-EtOH combined treatment increased the permeability more than As or EtOH treatment 
alone. RBE4 cells and BV2 cells showed an increase in ROS by the combined treatment. 
Mitochondrial ROS generation was increased by the combined treatment of As and EtOH 
but reduced by antioxidant Tempol in RBE4 cells and microglia BV2 cells. The combined 
treatment of As and EtOH decreased mitochondrial bioenergetics (mtBE) in RBE4 cells but 
increased by antioxidant Tempol. BV2 cells viability decreased as As or EtOH 
concentration increased and further decreased by the combined treatment. In conclusion, 
our results suggest that the combined treatment of As and EtOH induced toxicity on both 
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Chapter 1 Introduction 
1.1 Introduction of Arsenic (As) 
1.1.1 As Exposure 
As is a naturally occurring substance that can be found in air, water and soil. There are 
two forms of As, organic and inorganic. As combined with carbon which is referred to 
organic As is mainly found in seafood such as fish and shellfish. While As combined with 
other elements such as chlorine which is called inorganic As is more toxic than the organic 
form. Inorganic forms of As were used in pesticides, fungicides, paint pigment, wood 
preservations, etc. Although there is some limitations of As uses nowadays, the remained 
As still exists in the environment.  
As exists in several oxidation states, with As trioxide and As pentoxide being the most 
common forms. The major source of As exposure is groundwater used for drinking water in 
many countries such as Vietnam and Bangladesh [17-19]. According to the World Health 
Organization (WHO), at least 140 million people in 50 countries have been drinking water 
containing As at levels above the provisional guideline value of 10µg/L. The introduction of 
As into drinking water occurs as a result of its natural geological presence in local bedrock 
which is known in Bangladesh [20]. It is obvious that As exposure is a worldwide problem. 
1.1.2 As Toxicity 
Exposure to organic and inorganic As is associated with cancer and non-cancer effects 
in nearly every organ in the human body. Acute As poisoning results in nausea, vomiting, 
colicky abdominal pain, profuse watery diarrhea, excessive salivation and even death (lethal 
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dose: >100mg) [21]. Chronic As exposure affects a broad range of organs and system 
including skin, development processes, nervous system, respiratory system, cardiovascular 
system, liver, kidney, bladder, immune system and endocrine system [22]. Chronic 
exposure to As in drinking water caused skin lesions which is common symptom of As 
poisoning [23, 24]. In addition, As exposure results in different kinds of cancer such as skin 
cancer, lung cancer, bladder cancer and prostate cancer [25-28]. 
As exposure also affects the central nervous system, but it has not been extensively 
explored like As carcinogenic toxicity. For example, in Mexico, children who were exposed 
to As showed cognitive problems such as decreased intelligence quotients (IQ) scores, long-
term memory, linguistic abstraction, attention span and visuospatial organization [29, 30]. 
Chronic As poisoning patients had psychiatric manifestations including depression, anxiety 
and depression [31]. Different animal models also showed neurotoxicity after As exposure. 
(Table 1.1.2). Although the neurotoxic effects of As are wildly reported, the cellular and 
molecular mechanisms of As neurotoxicity have not well studied. Therefore, more research 











Table 1.1.2 Recent Animal studies on As neurotoxicity 
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1.2 Introduction of Ethanol (EtOH) 
Alcohol has historically, and continues to, hold an important role in social engagement 
and bonding for many. However, it is also known that alcohol drink leads to many health 
issues. In 2014, the World Health Organization reported that alcohol contributed to more 
than 200 diseases and injury-related health conditions. 
According to the 2015 National Survey on Drug Use and Health, 86.4 percent of 
people ages 18 or older reported that they drank alcohol at some point in their lifetime; 26.9 
percent of people ages 18 or older reported that they engaged in binge drinking in the past 
month in the United States. The Substance Abuse and Mental Health Service 
Administration defines binge drinking as 5 or more alcoholic drinks for male or 4 or more 
alcoholic drinks for females on the same occasion on at least 1 day in the past month. 
Alcohol use disorder has a life time prevalence of nearly one in three individuals in the 
United States [38]. 
Alcohol affects many parts of the human body including brain, heart, liver, pancreas, 
and immune system, which can cause many health problems such as cancer, cardiovascular 
diseases, liver diseases, depression and brain injury [39-42]. When alcohol is consumed, 
around 33% of it gets absorbed immediately into the blood. Once in the bloodstream, EtOH 
easily diffuses into the brain and leads to neurotoxicity. Different animal models were used 
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1.3 As and EtOH 
Alcohol drink may be contaminated with As as a result of poor quality management. 
Grapes and rice which are traditionally used to made wine and beer, take up As from soil, 
water, and fungicides containing As [46]. The filtering process used to remove sediment 
from beer and wine could contaminate alcohol drinks with potentially dangerous heavy 
metals such as As. Researchers collected 65 representative wines from the top four wine 
producing states in the U.S.A. and found that all samples contain a level of As that exceeds 
the U.S.A. Environment Production Agency exposure limit which is less than 10 parts per 
billion in drinking water [47]. Dangerously high levels of As have been found in drinking 
water wells in more than 25 states in the United States, potentially exposing 2.1 million 
people to drinking water with As concentration more than 10µg/L [48]. Although the 
number of people who exposed to both As and EtOH at the same time around the world is 
still not clear, there is high prevalence of co-exposure of As and EtOH. 
The combined treatment of As and EtOH induced toxicity in cancer and liver disease. 
For example, in colon cancer cells, EtOH enhances low-dose As induced tumor 
angiogenesis which is related to intracellular ROS generation, NASPH oxidase activation, 
and upregulation of PI3K/Akt and hypoxia-inducible factor 1 alpha signaling [49].  Not 
only the combined treatment with As and EtOH affects cancer, but also liver. In zebrafish, 
inorganic As increased the unfolded protein load in endoplasmic reticulum by directly 
acting as a reducing agent and indirectly by disrupting the redox balance through ROS 
generation, which potentiate the effect of EtOH to cause fatty liver disease [50]. Therefore, 
ROS generation is associated with the combined effects of As and EtOH. However, the 
cellular effects of As and EtOH co-exposure in the brain still needs to be studied.   
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1.4 Introduction of the Blood Brain Barrier (BBB) 
1.4.1 BBB 
The blood –brain barrier shields the brain from toxic substance. It tightly controls 
molecule and cell exchange between cerebral and peripheral compartments [3]. The precise 
control of central nervous system homeostasis allows for proper neuronal function and also 
protects the neural tissue from toxins and pathogens [51]. Alterations of the BBB are an 
important component of pathology and progression of different neurological diseases 
including traumatic brain injuries, Alzheimer’s disease, stroke, epilepsy and multiple 
sclerosis [4]. 
Both organic As and inorganic As have been reported to cause impairment of the BBB. 
As-containing hydrocarbons, a subgroup of arsenolipids enhances the permeability of the in 
vitro BBB which facilitates the transfer of toxicants into the brain [52]. Developmental As 
exposure significantly alters tight junction proteins, resulting in increased BBB 
permeability [5]. Besides As, EtOH also affects the BBB. Chronic alcohol drinking 
augmented and dysregulated the lipopolysaccharide-induced BBB abnormalities [6]. 
However, the effects of combined treatment of As and EtOH in the brain is still unclear. 
1.4.2 Brain Endothelial cells 
The BBB constitutes a neurovascular unit formed by microvascular endothelial cells, 
pericytes and astrocytes [53]. BBB endothelial cells display stringent tight junctions and 
which formed by tight junction proteins such as Occludin, Claudin [54]. The tight junction 
constitutes the barrier both to the passage of ions and molecules through the paracellular 
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pathway and to the movement of proteins and lipids between the apical and the basolateral 
domains of the plasma membrane [55]. Therefore, brain endothelial permeability plays a 
crucial role in the BBB.  
In this research, Rat Brain Endothelial (RBE4) cells were used to study the effects of 
combined treatment of As and EtOH on brain endothelial. Previously, our lab showed that 
As increased endothelial cell permeability through a ROS-vascular endothelial growth 
factor pathway in mouse brain vascular endothelial cells [8]. Animal study showed that As-
fed mice showed microvascular dysfunction with increased vascular leakage [56]. Not only 
As affects endothelial cells but also EtOH. Long term EtOH treatment leads to 
downregulation of tight junction proteins and loss of structural integrity in human cerebral 
microvascular endothelial cells [57]. However, the combined effects of As and EtOH on the 
brain have not been fully understood. 
1.5 Introduction of Oxidative Stress 
1.5.1 Oxidative Stress and ROS 
Oxidative stress reflects an imbalance between the systemic manifestation of reactive 
oxygen and nitrogen species and a biological system’s ability to readily detoxify the 
reactive intermediates or to repair the resulting damage. ROS contains unpaired electrons 
which increase the chemical reactivity of an atom or molecule, for example, hydroxyl 
radical (•OH) and superoxide anion (O-2). Two endogenous sources of ROS are the 
mammalian CYP-dependent microsomal electron transport system and the mitochondrial 
electron transport chain.   
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Oxidative stress causes toxic affects through damaging the cellular components 
including proteins, lipids and DNA, which is associated with different diseases.  Studies 
showed that oxidative stress is associated with neurodegenerative diseases, cardiovascular 
diseases and cancer. Clinical and preclinical studies indicate that neurodegenerative 
diseases are characterized by high levels of oxidative stress biomarkers and by lower levels 
of antioxidant defense biomarkers in the brain [58]. Oxidative stress accounts for impaired 
endothelial function, a process which promotes atherosclerotic lesion or fatty streaks 
formation [59]. Increased ROS production has been detected in various cancers and has 
been shown to have several roles in activating pro-tumorigenic signaling, enhancing cell 
survival and proliferation [60]. 
1.5.2 Oxidative Stress Affects the BBB 
The brain, with its high oxygen consumption and lipid-rich content, is highly 
susceptible to oxidative stress which involved in both neurodegenerative and 
neuropsychiatric disorders. ROS trigger a variety of molecular cascades that increase BBB 
permeability and later alter brain morphology, causing neuroinflammation and neuronal 
death [61].  
One of the effects of oxidative stress on the brain is altering the BBB which plays an 
essential role in protecting the brain. Oxidative stress contributes to enhanced BBB 
permeability in blast-induced traumatic brain injury [62]. Studies also showed that 
increased endothelial oxidative stress has a focal role in psychostimulant-induced BBB 
dysfunction by endothelial activation and regulation of BBB tight junction function [63]. 
However, inhibition of ROS could effectively protect the silica nanoparticles induced BBB 
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dysfunction including tight junction loss of brain microvessel endothelial cells [64]. Anti-
oxidant oleuropein protects intracerebral hemorrhage induced disruption of the BBB 
through alleviation of oxidative stress [65]. 
1.5.3 Oxidative stress and Mitochondrial Dysfunction 
The mitochondria is responsible for producing energy (adenosine triphosphate) by 
consuming oxygen. In normal condition, 1-5% oxygen is converted to ROS in 
mitochondria, thus the major production of intracellular oxidative stress is from 
mitochondria [66]. The electron transport chain which occurs in the inner membrane of the 
mitochondria produce adenosine triphosphate for cells with the involvement of different 
mitochondrial complexes. In fact, 0.2-2% of the electrons in the mitochondrial electron 
transport chain directly leak out and interact with oxygen to produce superoxide or 
hydrogen peroxide, which mainly located at mitochondrial complex I and complex III [67].  
Actually, mitochondria not only is the source of ROS but also is the target of oxidative 
stress. ROS damage the mitochondrial proteins/enzymes, membranes, and DNA, which 
leads to the interruption of energy generation and other essential functions in mitochondria 
[68]. It has been known that mitochondria dysfunction is associated with numerous 
neurodegenerative disorders including Parkinson’s disease, Alzheimer’s disease, 
Huntington’s disease and cerebral stroke [69]. Recently, researchers pay more and more 
attention on mitochondrial biology and several novel avenues in drug designing against 





Antioxidants are substances that help to prevent the harmful effects of excessive ROS 
activity, and combat or delay cell damage. Several antioxidants have been exploited in 
recent years for their actual or supposed beneficial effects against oxidative stress, such as 
vitamin E, flavonoids, and polyphenols [71]. Animal experiments have proved that the use 
of antioxidants is a beneficial therapeutic strategy of the treatment of diabetic retinopathy 
which is one of the most common microvascular complications of diabetes, but more data 
are required from clinical trials [72]. 
Tempol (4-hydroxy-2, 2, 6, 6,-tetramethylpiperidine-N-oxyl) is a redox-cycling 
nitroxide water-soluble superoxide dismutase mimetic that has been reported to be an 
effective antioxidant in detoxifying ROS both in cell culture and animal studies [73].  
Research showed that a Tempol has a protective effect against post-traumatic stress disorder 
induced short- and long- term memory impairment through prevention of alteration in 
oxidative stress in the hippocampus [74]. In addition, Tempol inhibits superoxide anion-
induced inflammatory pain in mice from molecular levels to behavioral alterations [75]. In 
this research, we will use Tempol as antioxidant to rescue the effect of As, EtOH and As 
with EtOH in cell models. 
1.6 Introduction of Inflammation  
1.6.1 Microglial cells 
A number of nervous system disorders are characterized by a state of inflammation in 
which members of the innate immune system, mostly notably microglia acting as single 
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entities and in unison produce inflammatory molecules that play major roles [76]. Activated 
microglia were found surrounding lesions of various neurodegenerative diseases, such as 
Alzheimer’s disease, Parkinson’s disease, muscular degeneration and necrosis, are involved 
in the removal of necrotic neurons [16].  
Microglial pro-inflammatory activation is associated with increased 
cytokine/chemokine expression, oxidative stress, which in turn leads to neuroinflammation 
which damages critical support cells such as brain endothelial cells that from the BBB [77]. 
Methylprednisolone sodium succinate, a well-known immunosuppressive agent, 
significantly suppressed activation of microglia and reduced permeability of the BBB in 
post-intracranial hemorrhage mice [78]. On the other hand, disruption of the BBB changes 
in blood flow, introduction of pathogens in the sensitive central nervous system niche, 
insufficient nutrient supply, and abnormal secretion of cytokines or endothelial receptors 
are reported to prime and attract microglia [79]. 
In this research, BV2 microglial cells will be used to study the effects of combined 
treatment of As and EtOH on microglia.  
1.6.2 Inflammation Affects the BBB 
Inflammation is part of the complex biological response of body tissues to harmful 
stimuli, such as pathogens, damaged cells or irritants, and is a protective response involving 
immune cells, blood vessels, and molecular mediators. There is increasing recognition that 
inflammation plays a critical role in the BBB alteration. Systemic inflammation leads to 
both disruptive BBB change (modification of tight junctions, endothelial damage) and non-
disruptive change which occurs at the molecular level [80]. 
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Microglia are known to express IL-1 7A and IL-1 7C receptors, which upon 
intracellular signaling can trigger the release of pro-inflammatory cytokines and a wide 
range of chemokines involved in leukocyte trafficking such as Monocyte Chemoattractant  
Protein 1 (MCP-1) [81]. MCP-1 was shown to increase BBB permeability by binding BBB-
EC-expressed chemokine C-C motif receptor 2, which in turn activates small GTPase Rho 
and Rho kinase to trigger the reorganization of the actin cytoskeleton and redistribution of 
TJ proteins [82].   
Pro-inflammatory cytokines stimulate gene expression of adhesion molecules such as 
Intercellular Adhesion Molecule-1(ICAM-1) [83]. ICAM-1 induced loss of tight junction 
proteins occluding and ZO-1 from cerebral vascular endothelium during neutrophil-induced 
BBB breakdown in vivo [84]. Increase of soluble inflammation mediators such as Vascular 
Endothelial Growth Factor (VEGF) activates several membrane receptors that converge in 
cellular pathways hallmark of inflammation leading to phosphorylation of tight junction 
proteins [85]. Anti-inflammatory effects of 3-hydroxy-3-methylglutaryl coenzyme A 
reductase inhibitor reduced BBB permeability restricting the diffusion of molecular tracers 
and the migration of immune cells across the BBB [86].  
Activated microglia produced ROS which further contribute to increased BBB 
permeability by activating the PI3K/AKT pathway and by decreasing the expression of VE-
cadherin, occluding and claudin-5 in BBB-ECs [87]. Microglia can also increase BBB 
permeability through secretion of Matrix Metallopeptidase (MMPs) [81]. MMPs induce 
degradation of tight junction proteins, breakdown of the extracellular matrix and subsequent 
loss of BBB integrity [88]. 
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1.6.3 Inflammation and oxidative stress 
Increasing evidence showed an important relationship between inflammation and 
oxidative stress. Oxidative stress is central in the pathology both as an initiator of vascular 
and renal inflammation and the consequence of inflammatory responses and cytokines [89]. 
At the site of inflammation, inflammatory cells such as neutrophils, monocytes, and 
lymphocytes trigger the release of various enzymes, including ROS, pro-inflammatory 
cytokines and other chemical mediators inducing oxidative stress [90]. Deregulation of the 
mitochondria electron transport chain, with increased mitochondrial ROS levels, was 
observed in inflammatory bowel disease patients and decreasing mitochondrial ROS 
ameliorated colitis [91]. Various inflammatory stimuli such as excessive ROS produced in 
the process of oxidative metabolism and some natural or artificial chemicals have been 
reported to initiate the inflammatory process resulting in synthesis and secretion of pro-
inflammatory cytokines. 
1.7 Statement of purpose  
As is a toxic metalloid that affects almost every organ including the brain. It is widely 
distributed throughout the environment especially in the groundwater. After As exposure, 
human beings across all age develop neurological and cognitive dysfunction, including 
learning and memory deficits as well as mood disorders [92, 93]. EtOH is also a common 
toxic substance affects the brain. In addition, EtOH is associated with transient neurological 
dysfunction as well as deficits in cognitive and motor domains [94, 95]. Recently, 
researchers have found that combined treatment of As and EtOH increases toxicity in 
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cancer and liver disease [50, 96], but the effects of the combined treatment on brain are still 
unclear. 
The BBB regulates the movement of ions, molecules and cells between the blood and 
the brain. It protects the neural tissue from toxins and pathogens [51]. Disruption of the 
BBB leads to neurological diseases and contributes to cognitive changes [97]. Since the 
properties of the BBB are largely manifested with the endothelial cells which form the walls 
of the blood vessels [51], rat brain endothelial cells ( RBE4 cells) are used to investigate the 
effects of As and EtOH on the BBB.  
Previously, our lab showed that As induced mouse brain endothelial cell permeability 
via oxidative stress that resulted from imbalance between the generation and detoxification 
of ROS [8]. Actually, oxidative stress induces BBB dysfunction though various pathways 
including mitochondrial alterations and direct mediation of BBB compromise such as tight 
junction modification [98]. Recent studies have shown that EtOH induces oxidative stress 
in the brains of animal models such as rat and zebrafish [99, 100]. Since brain endothelial 
cells contain a large number of mitochondria which is the major source of ROS generation, 
mitochondria may be a major target of As and EtOH neurotoxicity on the BBB. 
Oxidative stress is central in the pathology both as an initiator of vascular 
inflammation and the consequence of inflammation responses and cytokines [89]. There is 
an increasing recognition that inflammation plays a critical role in the BBB alteration.  
Elevated levels of pro-inflammatory cytokines leads to down-regulation of both junctional 
proteins and junctional complexes, ultimately contributing to endothelial cell 
permeabilization [101]. Microglial pro-inflammatory activation is associated with increased 
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cytokine expression, oxidative stress, which damages critical support cells such as brain 
endothelial cells [77]. Therefore, in this study, microglial cells (BV2 cells) were used to 
investigate the combined effects of As and EtOH on the BBB. 
Thus, we hypothesize that the combined treatment of As and EtOH induces toxic 
effects on both brain endothelial cells and microglial cells. To test this hypothesis, we will 
study the effects of As and EtOH on Rat Brain Endothelial Cells (RBE4 cells) and 
Microglial cells (BV2 cells) with the following specific aims:  
Aim 1: To determine the effects of As and EtOH on brain endothelial cells. After As 
and EtOH treatment, FITC-dextran leakage assay will be performed to assess the 
permeability of RBE4 cell monolayer. In addition, EPR and MitoSOX live cell staining will 
be performed to detect oxidative stress and mitochondria oxidative stress in treated RBE4 
cells. Also, mtBE assessment will be used to detect mitochondria dysfunction in treated 
RBE4 cells. We expect that the co-treatment increased RBE4 cell monolayer permeability, 
oxidative stress, mitochondria oxidative stress and induced mitochondria dysfunction more 
than either As or EtOH treatment alone. 
Aim 2: To determine the effects of As and EtOH on microglial cells. After As and 
EtOH treatment, MTT assay will be performed to investigate the effects of As and EtOH on 
the BV2 cells viability. In addition, EPR and MitoSOX live cell staining will be performed 
to detect oxidative stress and mitochondria oxidative stress in treated BV2 cells. We expect 
that the co-treatment increased cell death, oxidative stress, mitochondria oxidative stress 
more than either As or EtOH treatment alone. 
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The proposed studies will help us to gain more information regarding the mechanistic 
effects of As and EtOH induced toxicity on endothelial cells and microglial cells, which 
gives some support to find a potential therapeutic approach to prevent or reduce the 
















Chapter 2 Materials and Methods 
2.1 Reagents 
Table2.1 List of Major Reagents 
Name Company Catalog Number 
Collagen I CORNING 354236 
Sodium As SIGMA 71287 
TEMPO SIGMA 176141 
FITC-DEXTRAN SIGMA FD40S 
XF Assay Medium Seahorse Bioscience 102365-100 
Oligomycin SIGMA 75351 
FCCP SIGMA C2929 
Rotenone SIGMA R8875 
Antimycin A SIGMA A8674 
CMH Enzo Life Science ALX-430-117-M010 






2.2.1 Cell Culture and Treatment 
Rat brain endothelial cells (RBE4) were provided by Dr.Michael Aschner from the 
Albert Einstein College of Medicine. RBE4 cells were grown in T25 flask coated with 
50µg/ml rat tail collagen I (354236) within passage 20. The media of RBE4 cells consists of 
44% alpha-MEM (12571-063; Invitrogen), 44% Ham’s F-10 Nutrient (11550-043; 
Invitrogen), 10% fetal bovine serum, Geneticin and penicillin. RBE4 cells were kept in 
humidified incubator maintained in 37oC and 5% CO2. RBE4 cells media was replaced 
every 2 days. 2 days after seeding, RBE4 cells were treated with 5µM As, 80mM EtOH, 
and As combined with EtOH.  
Microglial cells (BV2) were obtained from Dr. Russell Swerdlow’s lab at The 
University of Kansas Medical Center. BV2 cells were grown in T25 flask coated with Poly-
D-lysine hydrobromide (P0899; Sigma). The media of BV2 cells consists of 90% DMEM 
(SH30022.01; HyClone), 10% fetal bovine serum and penicillin. BV2 cells were kept in 
humidified incubator maintained in 37oC and 5% CO2. BV2 cells media was replaced every 
2 days. 2 days after seeding, BV2 cells were treated with As, EtOH, and As combined with 
EtOH. As concentrations are 100nM, 200nM, 300nM. EtOH concentrations are 100mM, 







2.2.2 Paracellular Permeability Assay 
RBE4 cells were seeded in collagen I coated polyethylene terephthalate (PT) cell 
inserts (2×105 cells/cm2). The luminal compartments were filled with 300µl media and the 
abluminal compartments were filled with 600µl media. RBE4 cells were treated with As, 
EtOH, As with EtOH for 1, 3, 6 days. To determine the permeability of RBE4 cell 
monolayer, FITC-labeled dextran (MW 40,000, 1mg/ml) were added to the upper chamber 
and incubated for 3 hours. After incubation, 50µl of medium from the outside of the insert 
was taken and measure at the excitation wavelength of 492nm and the emission wavelength 
of 520nm by a fluorescent multi-mode microplate reader. 
2.2.3 mtBE Assessment 
Seahorse XF96 Analyzer was used to detect mtBE in RBE4 cells. RBE4 cells were 
seeded in XF96-well plates (50.000 cells per well) and incubated overnight. Then RBE4 
cells were treated with 5µM As, 80mM EtOH, and 5µM As combined with 80mM EtOH 
for 1 day. After treatments, XF assay medium (containing 5µM glucose, 1mM sodium 
pyruvate) was used to wash RBE4 cells twice. Before the experiment, RBE4 cells with XF 
assay medium were incubated without CO2 at least 1 hour. The sensor cartridge was loaded 
with 20µg/ml oligomycin, 2µM FCCP, 1µM rotenone with 1µM antimycin-A and XF assay 
medium. Once the sensor cartridge was equilibrated, the calibration plate was replaced with 
the cell plate. The Seahorse Analyzer using a 3 minute mix cycle to oxygenate the medium 





2.2.4 Electron Paramagnetic Resonance Spectroscopy (EPR) 
EPR instrument (Bruker BioSpin) was adopted for measuring superoxide in RBE4 
cells and BV2 cells. After one day treatment of As, EtOH, As with EtOH, RBE4 cells and 
BV2 cells were collected to prepare EPR samples. RBE4 cells or BV2 cells from 3 wells in 
6-well plates were trypsinized and collect for EPR measurement. Collected cells were 
treated with 1mM CMH for 3 hours. Then ice cold PBS was used to wash cells and store 
the sample at -80oC for analysis. 
Collect the sample to 50µL glass capillary tubes and use the Bruker e-scan EPR 
spectrometer to analyze the sample. Spectrometer settings were as follows: sweep width: 
100G; microwave frequency: 9.75 GHz; modulation amplitude: 1G; conversion time: 
5.12ms; time constant: 5.12ms; receiver gain: 2×102; number of scans: 30. Quantification 
of the EPR signal intensity was determined by comparing the intensity of the recorded 
middle derivative EPR peak of each sample. 
2.2.5 MitoSOX Live Cell Staining 
RBE4 cells were seeded at low density on Lab-Tek eight-well chamber slides and 
treated with As, EtOH, As with EtOH for one day. Mitochondrial ROS generation in treated 
RBE4 cells was measured by MitoSOX following the manufacture instructions. After 
treatment, RBE4 cells were washed with PBS and incubated with medium containing 
2.5µM MitoSOX for 20min. Next, cells were washed with PBS three times and incubated 
with 0.5µg/ml Hoechst 33342 in HBSS for 5min. Image were taken by Leica DMI4000 B 
microscope. At least two images from each well were collected and there were two wells in 
each treatment. Images were collected from 3 independent experiments and the 
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fluorescence intensity was calculated using Image J software. The corrected cell 
fluorescence intensity is calculated by integrated density minus area of cells multiply by 
mean fluorescence of background. Around 12 cells were counted for each images. In each 
experiment, different treatments of fluorescence intensity divided by the mean of 
fluorescence intensity in control groups to get the percentage of control.  
2.2.6 MTT Assay 
BV2 cells (1×104 cells/well) were seeded on Falcon 96-well culture plate coated with 
Poly-D-lysine hydrobromide and treated with 100, 200, 300nM As and 100, 200, 300mM 
EtOH; 100nM As combined with 50mM EtOH for one day. MTT solution was prepared at 
5mg/ml in PBS and was filtered through a 0.2µm filter. After removing old media in each 
well, 20µL of MTT were added into each well. Cells were incubated for 4 hours at 37oC 
with 5% CO2, 95% air and complete humidity. After 2-4 hours, the MTT solution was 
removed and replaced with 200µL of DMSO. The plate was further incubated for 10-30min, 
and the optical density (OD) of the wells was determined using a plate reader at a test 
wavelength of 570 nm and a reference wavelength of 630nm.  
2.2.7 Statistical Analysis 
 All data were collected from three independent experiments. One-way ANOVA was 
used to determine overall significance difference. Dunnett’s multiple comparisons test was 
applied to determine the significant difference in different groups compared to control. T-
test was used to determine the significant between two groups. All data are presented as 
mean ± SEM. Differences were considered statistically significant at P<0.05. 
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Chapter 3 Results 
3.1 As and EtOH Increased Permeability of RBE4 Cell Monolayer. 
Previously, our lab showed that 5µM As increased permeability of mouse brain 
vascular endothelial cell bEnd3 monolayer without inducing cell death [8]. Study of Shiu 
showed that 68mM alcohol increased the permeability of human brain microvascular 
endothelial cell monolayer without affecting cell viability [102]. However, the combined 
effects of As and EtOH on the endothelial cell permeability is still unknown. 
Rat brain endothelial (RBE4) cell monolayer permeability was assessed by FITC-
Dextran leakage assay which is widely used to determine endothelial cell monolayer 
permeability. After RBE4 cells growing to confluent monolayer on culture inserts, the cells 
were treated with 5µM As, 80mM EtOH, or both compounds for 6 days.  
As Figure 3.1 shown, the combined treatment of As and EtOH increased RBE4 cell 
monolayer permeability more than either As or EtOH treatment alone. After one day 
treatment, As or EtOH did not alter the permeability but the combined treatment 
significantly induced hyper-permeability of the RBE4 cell monolayer (*P<0.05). Although 
EtOH at 80mM did not significantly alter the permeability after one day treatment, EtOH 
significantly increased the permeability after 6 day treatment (*P<0.05). The combined 
treatment significantly increased the permeability compared to As which had stronger effect 












Figure 3.1 As and EtOH increased RBE4 cell monolayer permeability. 
Fluorescence of FITC-Dextran leaked from inserts to plate wells was assessed to determine 
the permeability after 1, 3, and 6 day treatment. Data was normalized to the control. A) 1 
day treatment. One-way ANOVA result showed there were statistically significant 
difference between group means. Dunnett’s multiple comparisons test showed that, 
compare to the control, the combined treatment significantly increased FITC-Dextran 
passage (*p<0.05). B) 3 day treatment. As One-way ANOVA result shown, there were 
statistically significant difference between group means. Dunnett’s multiple comparisons 
test showed that, compared to the control, As and the combined treatment significantly 
increased FITC-Dextran passage but not EtOH (*p<0.05). And T-test showed that the 
combined treatment significantly increased permeability compared to As treatment 
(#p<0.05). C) 6 day treatment. One-way ANOVA result showed there were statistically 
significant difference between group means. Dunnett’s multiple comparisons test showed 
that, compared to the control, As, EtOH, the combined treatment all significantly increased 
FITC-Dextran passage (*p<0.05).  And T-test showed that the combined treatment 
significantly increased permeability compared to As treatment (#p<0.05). Results were 









3.2 As and EtOH Increased ROS Production in RBE4 Cells. 
 Study of Lei demonstrated that antioxidant had an inhibitory effect on As-EtOH-
induced Cyclooxygenase-2 expression in colorectal cancer calls, indicating that the 
responsive signaling pathways from co-exposure to As and EtOH relate to ROS generation 
[96]. However, more studies are still needed on the combined effects of As and EtOH on 
ROS generation in brain endothelial cells. 
 It is known that increased oxidative stress is associated with the increased 
permeability of the BBB [61]. To determine whether As and EtOH induced oxidative stress 
in RBE4 cells, ROS levels in RBE4 cells were measured after one day treatment of 5µM 
As, 80mM EtOH, and As combined with EtOH. Electron paramagnetic resonance 
spectroscopy was used to determine the production of oxygen-derived free radical within 
treated RBE4 cells. 
As Figure 3.2 B shown, the combined treatment of 5µM As and 80mM EtOH 
significantly increased EPR signal in RBE4 cells but not As or EtOH treatment alone 
(*P<0.05). Therefore, co-exposure of As and EtOH significantly increased ROS generation 
more than either As or EtOH treatment alone.  




















Figure 3.2 As and EtOH increased ROS Production in RBE4 cells. A) EPR 
spectral profiles of ROS production from RBE4 cells after one day treatment with 5μM As, 
80mM EtOH, and As combined with EtOH. To detect levels of ROS, cell pellets were 
incubated with the spin probe CMH. B) Quantification of the EPR signal intensity was 
determined by comparing the intensity of the recorded middle-derivative EPR peak of each 
sample. Data were normalized to the control. As One-way ANOVA result showed that there 
were statistically significant difference between group means. Dunnett’s multiple 
comparisons test showed that the combined treatment significantly increased EPR intensity 


















3.3 As and EtOH Induced Mitochondrial ROS Production in RBE4 Cells. 
Study of Kathryn showed that As and EtOH upregulated the genes of mitochondrial-
associated endoplasmic reticulum membranes and a regulator of oxidative protein folding 
and endoplasmic reticulum redox homeostasis in the liver of zebrafish [50]. However, it is 
still unknown on the combined effect of arsenic and ethanol on mitochondria in brain 
endothelial cells. 
One of the sources of ROS generation is mitochondria. To investigate whether As and 
EtOH induced mitochondrial oxidative stress in RBE4 cells, live cell imaging of MitoSOX 
oxidation was used to detect mitochondrial oxidative stress in RBE4 cells after one day 
treatment of 5µM As, 80mM EtOH, and As combined with EtOH.  
As Figure 3.3A shown, the combined treatment of As and EtOH increased the red 
fluorescence of MitoSOX in RBE4 cells compared to control more than As or EtOH 
treatment alone. This effect was confirmed in Figure 3.3 B, the combined treatment 


















Figure 3.3 As and EtOH increased mitochondrial ROS production in RBE4 cells. 
RBE4 cells were incubated with MitoSOX and Hoechst 33342 to label mitochondrial 
superoxide radical (red) and nuclei (blue) respectively. A) As and EtOH increased 
mitochondrial ROS production. Scale bar, 20µm, objective, 40X B) Quantification of 
MitoSOX staining intensity. The mean fluorescence intensity per image was calculated and 
averaged over three images by Image J software. Around 12 cells were counted for each 
images. In each experiment, different treatments of fluorescence intensity divided by the 
mean of fluorescence intensity in control groups to get the percentage of control. As One-
way ANOVA result shown, there were statistically significant difference between group 
means. Dunnett’s multiple comparisons test showed that the combined treatment 
















3.4 As and EtOH affect mtBE in RBE4 cells. 
In cells and organs with high-energy demand, there is a high density of mitochondria 
that produce ROS as a by-product of mitochondria respiration, because the electron 
transport chain is not 100% efficient, which makes electrons escape from electron transport 
chain complexes and reduce oxygen to produce ROS [103]. To investigate the effects of the 
combined treatment of As and EtOH on mtBE in RBE4 cells, Seahorse extracellular flux 
analyzer was used for real-time measurements of oxygen consumption and provide an 
overall assessment of cellular mtBE. 
The ATP-linked respiration was estimated by the decrease in OCR followed by 
oligomycin, an ATP synthase inhibitor. As shown in Figure 3.4A, Basal and ATP-linked 
OCR of the combined treatment with As and EtOH decreased compared to the control. 
Residual OCR remaining after oligomycin is from uncoupled respiration. As shown in 
Figure 3.4A, proton leak OCR after the combined treatment with As and EtOH decreased 
compared to control. Maximal Respiratory Capacity (MRC) induced by FCCP, reflects the 
rate of maximal electron transport and substrate oxidation achievable in the absence of 
limits imposed by the inner mitochondrial membrane proton gradient. In Figure 3.4 B, the 
decrease in MRC in RBE4 cells after the combined treatment of As and EtOH suggested 



















Figure 3.4 As and EtOH affect mtBE in RBE4 cells. After one day treatment of As, 
EtOH, As with EtOH, oxygen consumption was measured. OCR was manipulated with 
injections of oligomysin, FCCP, rotenone with antimycin-A. A) Representative 
bioenergetics profile of RBE4 cells treated with 5µM As, 80mM EtOH and the combined 
treatment for one day. B) Quantification of MRC. MRC was achieved by adding FCCP 
which is protonophore. Data were normalized by the control.  As One-way ANOVA result 
shown, there were statistically significant difference between group means. Dunnett’s 
multiple comparisons test showed that As and the combined treatment significantly 
















3.5 Antioxidant Decreased As-EtOH-Induced Mitochondrial ROS Production in RBE4 
cells. 
Previously, our data showed that the combined treatment of 5µM As and 80mM EtOH 
significantly increased both cellular ROS and mitochondrial oxidative stress. To determine 
whether antioxidant can decrease As-EtOH-induced mitochondrial oxidative stress in RBE4 
cells, superoxide anion radical scavenger Tempol (500µM) was added with 5µM As, 80mM 
EtOH, and the combined two in RBE4 culture media. After one day treatment, live cell 
imaging of MitoSOX oxidation was used to detect mitochondrial oxidative stress in RBE4 
cells. 
As Figure 3.5A shown, all three treatment slightly increased the red fluorescence of 
MitoSOX in RBE4 cells compared to control. In addition, as shown in Figure 3.5 B, there 
is no significant effect of all three treatments on mitochondrial oxidative stress compared to 

















Figure 3.5 Antioxidant decreased As-EtOH-induced mitochondrial ROS 
production in RBE4 cells. RBE4 cells were incubated with MitoSOX and Hoechst 33342 
to label mitochondrial superoxide radical (red) and nuclei (blue) respectively. A) 
Antioxidant Tempol decreased As-EtOH-induced mitochondrial ROS production. Scale bar, 
20µm, objective, 40X B) Quantification of MitoSOX staining intensity. The mean 
fluorescence intensity per image was calculated and averaged over three images by Image J 
software. Around 12 cells were counted for each images. In each experiment, different 
treatments of fluorescence intensity divided by the mean of fluorescence intensity in control 
groups to get the percentage of control. As One-way ANOVA result shown, there were no 
















3.6 Antioxidant decreased As-EtOH-Induced mtBE Loss in RBE4 cells. 
Tempol which promotes the metabolism of many ROS has been shown to preserve 
mitochondria against oxidative damage[104]. After confirming that antioxidant Tempol can 
decrease As-EtOH-induced mitochondrial oxidative stress, we next to investigate whether 
antioxidant can also reduce As-EtOH-induced mitochondrial dysfunction in RBE4 cells.  
Previously, our data showed that the combined treatment of 5µM As and 80mM EtOH 
decreased maximum respiratory capacity in RBE4 cells, which is around 30%. As shown in 
Figure 3.6 B, antioxidant Tempol significantly increased As-EtOH-induced decrease in 
maximum respiratory capacity, which is around 60% (#P<0.05). Although Tempol did not 
significantly increased As-induced MRC decrease, there is a trend for Tempol to increase 
MRC. Interestingly, Tempol had a trend to decreased EtOH-increased MRC from around 























Figure 3.6 Antioxidant reduced As-EtOH-induced mtBE loss in RBE4 cells. After 
one day treatment of 5µM As with 500µM Tempol, 80mM EtOH with 500µM Tempol, and 
As combined with EtOH and Tempol, oxygen consumption was measured. OCR was 
manipulated with injections of oligomysin, FCCP, rotenone with antimycin-A. A) 
Representative bioenergetics profile of RBE4 cells treated 500µM Tempol, 80mM EtOH 
with 500µM Tempol, and As combined with EtOH, Tempol for one day. B) Quantification 
of MRC. MRC was achieved by adding FCCP which is protonophore. Data were 
normalized by the control.  Compared with the Figure 3.4B. T-test showed that Tempol 
significantly increased the combined treatment induced decreased in MRC (#p< 0.05). 
















3.7 As and EtOH induced cell death in BV2 cells. 
Microglial cells are phagocytic cells of the central nervous system and have been 
proposed to be a primary component of the innate immune response and maintain efficient 
central nervous system [105]. To investigate the effects of As and EtOH on the cell viability 
of microglia BV2 cells, MTT assay was performed after one day treatment of 100, 200, 
300nM As and 100, 200, 300mM EtOH. 
As shown in Figure 3.7 A, after one day treatment, cell viability of microglia BV2 
cells decreased as As concentration increased. As significantly induced BV2 cells death at 
300nm, demonstrating a concentration-dependent effect (*P<0.05). Figure 3.7 B showed 
that EtOH induced microglia BV2 cells death with an increase in EtOH concentration. 
EtOH at 300mM significantly decrease BV2 cells viability (*P<0.05). The higher 
concentration of EtOH the lower BV2 cells survival. Therefore, both As and EtOH can 

























Figure 3.7 As and EtOH induced BV2 cells death. A) After one day treatment of 
100, 200, 300nM As, BV2 cells viability decreased as As concentration increased. As One-
way ANOVA result shown, there were statistically significant difference between group 
means. Dunnett’s multiple comparisons test showed that 300nM As significantly decreased 
BV2 cells viability. (*P<0.05) B) After one day treatment of 100, 200, 300mM EtOH, BV2 
cells viability decreased as EtOH concentration increased. As One-way ANOVA result 
shown, there were statistically significant difference between group means. Dunnett’s 
multiple comparisons test showed that 300mM EtOH significantly decreased BV2 cells 


















3.8 The combined treatment of As and EtOH decreased cell viability in BV2 cells. 
As demonstrated above, our data showed that As and EtOH caused death of microglia 
BV2 cells. We further investigate the effects of combined treatment of As and EtOH on 
BV2 cells. BV2 cells were treated with 100nM As, 50mM EtOH, and As combined with 
EtOH for one day. After treatment, MTT assay will be performed to detect the combined 
effects of As and EtOH on BV2 cells. 
As shown in Figure 3.8A, there were fewer BV2 cells in As, EtOH, and especially the 
combined treatment than control. The combined treatment decreased BV2 cells number 
more than As or EtOH treatment alone. In Figure 3.8 B, MMT assay result confirmed the 
combined effects of As and EtOH on BV2 cells viability. The combined treatment of As 
and EtOH significantly decreased BV2 cells viability but not As or EtOH treatment alone 
(*P<0.05). 
Therefore, the combined treatment of As and EtOH can induce microglial cells death 

























Figure 3.8 The combined treatment of As and EtOH induced BV2 cells death. A) 
After one day of 100nM As, 50mM EtOH, and combined two treatment, images of treated 
BV2 cells were collected. Scale bar, 20µm, objective, 10X B) After one day of 100nM As, 
50mM EtOH, and combined two treatment, BV2 cells viability decreased in the combined 
treatment in MTT assay. As One-way ANOVA result shown, there were statistically 
significant difference between group means. Dunnett’s multiple comparisons test showed 
that the combined two treatment significantly decreased BV2 cells viability compared to the 



















3.9 As and EtOH Increased ROS Production in BV2 Cells. 
Microglia detect and respond to a diverse array of stimuli in the brain, including 
environmental toxins, where the pro-inflammatory response activation state is characterized 
by the upregulation of pro-inflammatory mediators and the production of ROS [106]. To 
investigate the effects of As and EtOH on microglia, electron paramagnetic resonance 
spectroscopy was used to determine the production of ROS within treated microglia BV2 
cells.  
As Figure 3.9 A shown, both 50nM As and the combined treatment with 50nM As and 
20mM EtOH increased EPR signal compared to control. And as Figure 3.9 B shown, As 
and the combined treatment significantly induced EPR signal compared to control 
(*P<0.05). Therefore, the combined treatment of As and EtOH can induce intracellular 


























Figure 3.9 As and EtOH Increased ROS Production in BV2 Cells. To detect levels 
of ROS, cell pellets were incubated with the spin probe CMH. A) EPR spectral profiles of 
ROS production from BV2 cells after one day treatment with 50mM As, 20mM EtOH, and 
the combined two. B) Quantification of the EPR signal intensity was determined by 
comparing the intensity of the recorded middle-derivative EPR peak of each sample. Data 
were normalized to the control. As One-way ANOVA result shown, there were statistically 
significant difference between group means. Dunnett’s multiple comparisons test showed 
that the combined treatment significantly increased EPR intensity compared to the control 


















3.10 As and EtOH Induced Mitochondrial ROS Production in BV2 Cells. 
Mitochondrial ROS have been proposed as important regulators of the inflammatory 
response in the innate immune system which is associated with microglia activation [11]. 
To investigate the effects of As and EtOH on mitochondrial ROS in microglial cells, live 
cell imaging of MitoSOX oxidation was used to detect mitochondrial oxidative stress in 
microglia BV2 cells after one day treatment of 50nM As, 20mM EtOH, and As combined 
with EtOH. 
As Figure 3.10A shown, the combined treatment increased the red fluorescence of 
MitoSOX in BV2 cells compared to As or EtOH treatment alone. In addition, as shown in 
Figure 3.10 B, the combined two treatments significantly increased MitoSOX intensity in 
BV2 cells but not As or EtOH treatment alone (*P<0.05). Therefore, the combined 
treatment of As and EtOH can increase mitochondrial oxidative stress more than either As 














Figure 3.10 As and EtOH increased mitochondrial ROS production in BV2 cells. 
After one day of 50nM As, 20mM EtOH, and As combined with EtOH treatments, BV2 
cells were incubated with MitoSOX and Hoechst 33342 to label mitochondrial superoxide 
radical (red) and nuclei (blue) respectively. A) As and EtOH increased mitochondrial ROS 
production. Scale bar, 20µm, objective, 40X B) Quantification of MitoSOX staining 
intensity. The mean fluorescence intensity per image was calculated and averaged over 
three images by Image J software. Data were normalized by the control. As One-way 
ANOVA result shown, there were statistically significant difference between group means. 
Dunnett’s multiple comparisons test showed that the combined treatment significantly 
increased MitoSOX intensity compared to the control (*p< 0.05). Results were presented as 














3.11 Antioxidant Decreased As-EtOH-Induced Mitochondrial ROS Production in BV2 
cells. 
Previously, our data showed that the combined treatment of 50nM As and 20mM 
EtOH significantly increased both cellular ROS and mitochondrial oxidative stress. To 
determine whether antioxidant can rescue As-EtOH-induced mitochondrial oxidative stress 
in microglia BV2 cells, superoxide anion radical scavenger Tempol (500µM) was added 
with 50nM As, 20mM EtOH, and As combined with EtOH in BV2 cells culture media. 
After one day treatment, live cell imaging of MitoSOX oxidation was used to detect 
mitochondrial oxidative stress in BV2 cells. 
As Figure 3.11A shown, all three treatments slightly increased the red fluorescence of 
MitoSOX in BV2 cells compared to control. In addition as shown in Figure 3.11 B, there is 
no significant effect of all three treatments on mitochondrial oxidative stress compared to 
the control. Therefore, antioxidant can rescue the effect of As, EtOH, As with EtOH on 














Figure 3.11 Antioxidant decreased As-EtOH-induced mitochondrial ROS 
production in BV2 cells. After one day treatment of antioxidant Tempol with 50nM As, 
20mM EtOH, and the combined two, BV2 cell were incubated with MitoSOX and Hoechst 
33342 to label mitochondrial superoxide radical (red) and nuclei (blue) respectively. A) 
Antioxidant Tempol decreased As-EtOH-induced mitochondrial ROS production. Scale bar, 
20µm, objective, 40X B) Quantification of MitoSOX staining intensity. The mean 
fluorescence intensity per image was calculated and averaged over three images by Image J 
software. Around 12 cells were counted for each images. In each experiment, different 
treatments of fluorescence intensity divided by the mean of fluorescence intensity in control 
groups to get the percentage of control. As One-way ANOVA result shown, there were no 
















Chapter 4 Discussion 
Grapes and rice which are traditionally used to made wine and beer, take up As from 
soil, water, and fungicides containing As [46]. The filtering process used to remove 
sediment from beer and wine could contaminate alcohol drinks with potentially dangerous 
heavy metals such as As. Subsequently, this can cause people to be exposed to alcohol and 
As together. The combined treatment of As and EtOH induced toxicity in cancer and liver 
disease. For example, in colon cancer cells, EtOH enhances low-dose As induced tumor 
angiogenesis which is related to intracellular ROS generation, NASPH oxidase activation, 
and upregulation of PI3K/Akt and hypoxia-inducible factor 1 alpha signaling [49]. In 
zebrafish, inorganic As increased the unfolded protein load in endoplasmic reticulum by 
directly acting as a reducing agent and indirectly by disrupting the redox balance through 
ROS generation, which potentiate the effect of EtOH to cause fatty liver disease [50]. 
Therefore, ROS play an important role on the combine effects of As and EtOH. However, 
the effects of As and ethanol co-exposure on the brain is still unclear. In this study, we 
focused on the combined effects of As and EtOH on brain endothelial cells and microglia 
cells. We hypothesized that As combined with EtOH induced toxicity on the blood brain 
barrier more severe than either As or ethanol treatment alone. 
The vasculature is often affected by, and engaged in, the disease process, resulting in 
hyperpermeable vessels which further promotes disease propagation [107]. It is believed 
that recovery of the normal vasculature requires diminishing this hyperpermeable state 
[108]. In this study, we have tested the effects of As and EtOH on the permeability of brain 
endothelial cells which mainly regulate the vasculature in the BBB by using FITC-Dextran 
leakage assay.  
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Previously, our lab showed that 5, 10, 15, 20 µM As increased permeability of the 
mouse brain vascular endothelial cells (bEnd3) monolayer through a ROS-vascular 
endothelial growth factor pathway [8]. In the current studies, we chose 5µM As which is in 
the range of As concentration in the environment. For example, in Nepal, the concentration 
of As in tube wells water is range from around 100µg/L (1.33µM) to 800µg/L (10.64µM) in 
2018 [109].  
In addition to As, EtOH is also associated with the permeability of the endothelial 
cells. EtOH actions on the endothelial transient receptor potential channels could affect 
intracellular Ca2+ and Mg2+ dynamics, which mediate leukocyte adhesion to endothelial 
cells and endothelial permeability at the BBB, thus altering immune and inflammatory 
response [110].  
In our study, we chose 80mM EtOH which is in the concentration range (5-200mM) 
used in many previous publications [111, 112]. Our results showed that both As and EtOH 
induced hyper-permeability of RBE4 cell monolayer and the combined treatment further 
increased the permeability. Although endothelial cells play an important role in BBB 
permeability, the effects of As and EtOH on these cells have not been well studied. 
Therefore, more research is needed to gain more information about the effect of the As and 
EtOH combined treatment on the permeability of the BBB in vivo. 
Dysfunction of the BBB, which is induced by oxidative stress is associated with loss of 
neurons, altered brain functions such as impaired consciousness, memory, and motor 
impairment by up-regulating expression of cell adhesion molecules on the surface of the 
brain vascular endothelium [113]. In addition, oxidative stress is an important factor 
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contributing to endothelial dysfunction and is linked with increased ROS production and 
decreased availability of antioxidants [114]. Research showed that oxidative stress induced 
vascular endothelial growth factor can activate a series of steps leading to internalization of 
vascular-cadherin and breakdown the adherent junctions between endothelial cells [115]. In 
this study, we proposed that the combined treatment of As and EtOH induced oxidative 
stress leading to hyperpermeability of the brain endothelial. 
 Previously, our lab found that As elevated cellular ROS generation in mouse brain 
vascular endothelial cells bEnd3, and antioxidant NAC, Tempol can rescue this effect [8]. 
Research showed that EtOH intake induced an increase in ROS generation in freshly 
isolated endothelial cells from EtOH-treated rats [116]. To investigate the combined effects 
of As and EtOH on endothelial oxidative stress generation on rat brain endothelial cells, 
electron paramagnetic resonance spectroscopy was used to determine the production of 
oxygen-derived free radical within treated RBE4 cells. Our results showed that the 
combined treatment of 5µM As and 80mM EtOH increased oxidative stress higher than 
either As or EtOH treatment alone. Since oxidative stress plays an important role on the 
BBB, it is necessary to determine the source of ROS. 
The brain is a high energy consuming organ that requires about 20% of body basal 
oxygen to fulfill its function [117]. In cellular level, energy is mainly provided via oxidative 
phosphorylation taking place within mitochondrial. When mitochondria provide energy for 
cell survival, ROS are also formed through this process. In normal condition, 1-5% oxygen 
is converted to ROS in mitochondria, which makes mitochondria is one of the major 
sources of intracellular oxidative stress [66].  
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Research showed that As treated rats exhibited about 35% increase in 2’, 7’ 
dichlorofluorescin diacetate signal fluorescence comparing to controls, suggesting that 
higher mitochondrial ROS accumulation after As treatment in rat brains [118]. In addition, 
synaptosomes from alcohol-treated mice showed an increase in MitoSOX fluorescence 
median compared with control group, suggesting EtOH induced mitochondrial oxidative 
stress in synaptosomes [119]. Therefore, we proposed that the combined treatment of As 
and EtOH induced mitochondrial oxidative stress on brain endothelial cells. 
To investigate the combined effects of As and EtOH on mitochondrial ROS generation 
on rat brain endothelial cells, live cell imaging of MitoSOX oxidation was used to detect 
mitochondrial oxidative stress in RBE4 cells after one day treatment of 5µM As, 80mM 
EtOH, and the combined two. Our results showed that the combined treatment significantly 
induced mitochondrial oxidative stress more than either As or EtOH treatment alone. Since 
mitochondria dysfunction can cause mitochondrial oxidative stress, next we focus on the 
combined effects of As and EtOH on mitochondria bioenergetics in brain endothelial cells. 
Mitochondrial function is impaired during the production of ROS, which is currently 
considered as a critical role in the development and progression of disease. In addition, 
cellular oxygen consumption is increasingly recognized as a fundamental measure of 
mitochondrial function. In this study, Seahorse XF96 Analyzer was used to detect the OCR 
of rat brain endothelial cells after As and EtOH treatment.  
Basal OCR reflects coupled mitochondrial respiration as well as uncoupled 
consumption of oxygen to form ROS at mitochondrial and non-mitochondrial enzymatic 
sites. Our results showed that treatment with As decreased the basal OCR compared to the 
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control. The basal OCR is depends on the availability of the substrate such as glucose and 
pyruvate involving nutrient conditions. As can enter mitochondrial via aquaglyceroporins, 
where it can bind and inhibit numerous enzymes involved in energy production including 
pyruvate [120]. Research showed that hepatocyte basal respiration can be greatly increased 
by addition of pyruvate [121]. Therefore, alteration in nutrient conditions such as decrease 
in pyruvate level may be considered as one of phenomena that explain why As decreased 
the basal OCR. 
Coupled and uncoupled respiration can be distinguished by examining the effect of an 
inhibition of ATP synthase (oligomycin) and Complex III (antimycin A). While maximal 
OCR, provoked by addition of a mitochondrial uncoupling agent such as carbonyl cyanide 
p-(trifluoromethoxy) phenylhydrazone (FCCP), provides an index of energetic reserve 
capacity. The decreased maximal OCR indicates mitochondrial dysfunction. Our results 
show that the combine treatment of As and EtOH decreased MRC indicating mitochondrial 
dysfunction. Interestingly, our results showed that EtOH trend to increased MRC compared 
to the control but antioxidant trend to decrease this effect. Previously, our data showed that 
EtOH trend to induce endothelial hyperpermeability, cellular oxidative stress, and 
mitochondrial ROS generation. Therefore, excessive increased in mitochondrial MRC may 
also indicates mitochondrial dysfunction.  
Microglial cells are a specialized population of macrophages that are found in the 
central nervous system. As the resident macrophage cells, they act as the first and main of 
active immune defense in the central nervous system. The BBB constituted by an extensive 
network of endothelial cells together with neurons and glial cells, including microglia, 
forms the neurovascular unit. The crosstalk between these cells guarantees a proper 
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environment for brain function. Therefore, microglial cells play an important roles in the 
BBB. 
 In the second part of our study, we used mouse brain microglial cells (BV2 cells) to 
investigate the combined effects of As and EtOH on the microglia. BV2 cells are a useful 
cell line because they can be maintained in culture, yet they keep many of the functions and 
features that microglia express in vivo [122]. To detect the effects of As and EtOH on the 
cell viability of BV2 cells, MTT assay was performed. Our results showed that both As and 
EtOH decreased BV2 cells viability and the combined treatment can further induce BV2 
cells death.   
After As and EtOH getting into the blood stream, As and EtOH need to pass the brain 
endothelium formed by brain endothelial cell first in order to enter the brain. Brain 
microglia which is the major sources of pro-inflammatory cytokines expression in the brain 
can then interact with As and EtOH that successfully passed from brain endothelium. Our 
results showed that mouse brain microglial cells are more susceptible to As and EtOH than 
rat brain endothelial cells, which matches the real condition. Study of Singh showed that 
500nM As and IFN-γ increased pro-inflammatory cytokines expression in microglia cell 
line (N9) [123]. Previously, our lab showed that 5µM As increased permeability of mouse 
brain vascular endothelial cell (bEnd3) monolayer [8]. EtOH increased superoxide anion 
generation in cultured neonatal hamster microglia and this effect was maximal at 20mM 
[124]. EtOH at 200Mm decreased tight junction proteins expression in human cerebral 
microvascular endothelial cells[57]. 
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Activated microglia migrate and release pro-inflammatory cytokines that contribute to 
disruption of the BBB, neuronal loss, and enhanced ROS production [125]. To investigate 
the combined effects of As and EtOH on ROS generation on microglia BV2 cells, electron 
paramagnetic resonance spectroscopy was used to determine the production of oxygen-
derived free radical within treated BV2 cells. Our results showed that the combined 
treatment of As and EtOH significantly increased ROS more than either As or EtOH 
treatment alone. Therefore, As and EtOH can activate microglial cells, which is a hallmark 
of brain pathology. 
 In addition, similar to rat brain endothelial cells, As and EtOH induced mitochondrial 
oxidative stress while antioxidant can rescue this effect. However, targeted delivery of 
antioxidant to mitochondrial has failed to translate into clinical success due to their 
nonspecific cellular localization, poor transport properties across multiple biological 
barriers, and associated side effects [126]. Since the function of the mitochondria is 
complex, more study still needed to find a way to rescue mitochondrial oxidative stress in 
clinical use.  
A study showed that ROS can lead to different molecular cell death mechanisms 
including necrosis and apoptosis [127]. Mild oxidative stress may activate biological 
response that can induce apoptosis, while the accumulation of high levels of ROS may 
promote necrosis instead [128]. In addition to the well-established role of the mitochondria 
in energy metabolism, regulation of cell death has recently emerged as a second major 
function of these organelles[129]. In a neuroblastoma cell line, oxidative stress induced 
necrotic cell death via mitochondria dependent burst of ROS [130]. During apoptosis, 
mitochondrial membrane permeability increases and the release into the cytosol of pro-
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apoptotic factors including procaspase, caspase activator and caspase independent factors 
such as apoptosis-inducing factor leads to the apoptotic phenotype [131]. Cytochrome c 
released from mitochondria, that triggers caspase activation, appears to be largely mediated 
by direct or indirect ROS action [132]. Our results showed the combined treatment of As 
and EtOH induced microglia cells death and antioxidant reduced mitochondria oxidative 
stress. Further studies are needed to investigate the role of mitochondrial oxidative stress on 
As-EtOH-induced microglia cells death. 
In this study, we investigated the combined effects of As and EtOH on the BBB by 
using brain endothelial cells and microglial cells. However, the components of the BBB are 
complicated. Pericytes are multi-functional mural cells of the microcirculation that wrap 
around the endothelial cells that line the capillaries and venules. Astrocytes are essential for 
the formation and maintenance of the BBB and the formation of strong tight junctions. In 
vertebrates, the BBB formation is coordinated by interactions between neurons, glial cells 
and endothelial cells [133]. The limitation of our study is that it only focused on endothelial 
cells and microglial cells and there are other BBB cellular components else. Therefore, 
more studies are needed to investigate the effects of As and EtOH combined treatment on 
the BBB not only in endothelial cells and microglial cells. In addition, there is still a gap 
between in vitro and in vivo study. Animal studies are needed to investigate the effects of 
As and EtOH co-exposure on the BBB. 
In summary, our present results showed the combined effects of the As and EtOH on 
the brain endothelial cells and microglial cells (Figure 4.1). We have identified that the 
combined treatment of As and EtOH induced mitochondrial oxidative stress more than 
either As or EtOH treatment alone in RBE4 cells and BV2 cells, while antioxidant Tempol 
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can reduce this effect. The increased in mitochondria oxidative stress is associated with 
increased in ROS. Our results showed that both As and EtOH increased ROS level in 
endothelial cells and microglial cells. We investigated the permeability of endothelial cells 
and found that As with EtOH significantly increased RBE4 cells permeability. In 
conclusion, the combined treatment of As and EtOH induced toxicity in both brain 
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